SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000882104-19-000044
Filing Date
2019-04-30
Accepted
2019-04-30 17:08:48
Documents
11
Period of Report
2019-06-20
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A pdli-2019def14adoc.htm DEF 14A 1297226
2 a2019proxycard1.jpg GRAPHIC 263788
3 a2019proxycard2.jpg GRAPHIC 284687
4 dmsignature.jpg GRAPHIC 11435
5 gcsiga04.gif GRAPHIC 2504
6 graph1.jpg GRAPHIC 51584
7 graph2.jpg GRAPHIC 61551
8 graph3.jpg GRAPHIC 48506
9 graph4.jpg GRAPHIC 67817
10 graph5.jpg GRAPHIC 75178
11 pdllogoa12.jpg GRAPHIC 123123
  Complete submission text file 0000882104-19-000044.txt   2619203
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19756 | Film No.: 19783005
SIC: 2836 Biological Products, (No Diagnostic Substances)